NCT06058962View on ClinicalTrials.gov

Double Blind Trial in Children With Autism Spectrum Disorder

PHASE2CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

January 15, 2021

Study Completion Date

March 15, 2021

Conditions

Autism Spectrum Disorder

Interventions

DRUG

Suramin Sodium

Suramin sodium is a sodium salt form of suramin, an antitrypanosomal compound.

Trial Locations (1)

10591

PaxMedica, Tarrytown

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Paxmedica

INDUSTRY